title: Does elevated intraocular pressure reduce retinal TRKB-mediated survival signaling in experimental glaucoma?
abstract: Reduced retrograde transport of neurotrophins (NT) and their receptors has been hypothesized to contribute directly to retinal ganglion cell (RGC) loss in glaucoma. However, strategies of supplementing NT and NT receptors have failed to avert ultimate RGC death in experimental glaucoma. This study examines the response of major components of the NT system and their interacting proteins in a rat glaucoma model. Unilateral chronic intraocular pressure (IOP) elevation was produced by episcleral vein injection of hypertonic saline (N = 99). Retinas were collected and grouped by extent of optic nerve injury. Quantitative reverse transcription PCR, western blot analysis and immunohistochemistry were used to determine mRNA and protein levels and protein localization. Out of three RGC-specific Brn3 proteins (Brn3a, b, and c), only Brn3a was significantly downregulated at the message level to 35 +/- 4% of fellow values with the severest nerve injury. With IOP elevation, no significant alterations were found in retinal mRNA levels for BDNF, NGF, NT-4/5 or NT-3. The abundance of mature retinal BDNF protein was not significantly affected by elevated IOP, while proBDNF protein decreased linearly with increasing injury grade (r(2) = 0.50). In retinas with the severest nerve injury, TrkB and TrkC receptor mRNA levels significantly declined to 67 +/- 9% and 44 +/- 5% of fellow values, respectively. However, the levels of TRKB protein and its phosphorylated form were unchanged. Message level for p75(NTR) was linearly upregulated up to 219 +/- 26% with increasing injury (r(2) = 0.46), but no alteration was detected at protein level. The mRNA expression of p75(NTR) apoptosis adaptor proteins NADE, NRIF, and Lingo1 were significantly downregulated in retinas with the greatest nerve injury. A positive correlation was found between injury extent and message levels for Jun (r(2) = 0.23) as well as Junb (r(2) = 0.27), and RGC labeling of activated JUN protein increased. Atf3 mRNA levels demonstrated a positive linear correlation to the extent of injury (r(2) = 0.53), resulting in a nearly five-fold increase (482 +/- 76%) in eyes with the greatest nerve damage. Among downstream pro-survival signaling components, Erk5 mRNA expression was linearly upregulated (r(2) = 0.32) up to 157 +/- 15% of fellow values in retinas with the severest nerve injury (p < 0.01). A slight positive correlation was found between NF-kappaB message levels and injury extent (r(2) = 0.12). Bcl-xl mRNA levels in the most severely injured retinas were significantly reduced to 83 +/- 7% by elevated IOP exposure. Message levels for Erk1/2, Akt1-3 or Bcl2 appeared unaffected. Elevated IOP did not alter mRNA levels of pro-apoptotic Bim, Bax, or p53. This study demonstrates that elevated IOP exposure does not result in a dramatic decrease in retinal levels of either BDNF or its receptor, TrkB. It shows that the responses of NT pathways to elevated IOP are complex, particularly with regard to the role of p75(NTR) and Atf3. A better understanding of the roles of these proteins in IOP-induced injury is likely to suggest informed strategies for neuroprotection in glaucoma.
authors.affiliation: The Kenneth C. Swan Ocular Neurobiology Laboratory, Casey Eye Institute, Oregon Health and Science University, 3375 SW Terwilliger Blvd, Portland, OR 97239, USA. johnsoel@ohsu.edu
authors.forename: Ying
authors.initials: Y
authors.lastname: Guo
authors.forename: Elaine
authors.initials: E
authors.lastname: Johnson
authors.forename: William
authors.initials: W
authors.lastname: Cepurna
authors.forename: Lijun
authors.initials: L
authors.lastname: Jia
authors.forename: Jennifer
authors.initials: J
authors.lastname: Dyck
authors.forename: John C
authors.initials: JC
authors.lastname: Morrison
mesh_terms: D000818:Animals; D019208:Brain-Derived Neurotrophic Factor / Q000096:biosynthesis / Q000235:genetics; D004195:Disease Models, Animal; D005136:Eye Proteins / Q000096:biosynthesis / Q000235:genetics; D005786:Gene Expression Regulation; D005901:Glaucoma / Q000378:metabolism* / Q000473:pathology / Q000503:physiopathology; D007429:Intraocular Pressure / Q000502:physiology; D009414:Nerve Growth Factors / Q000096:biosynthesis / Q000235:genetics; D009419:Nerve Tissue Proteins; D012333:RNA, Messenger / Q000235:genetics; D051381:Rats; D011914:Rats, Inbred BN; D020813:Receptor, trkB / Q000235:genetics / Q000502:physiology*; D017978:Receptors, Growth Factor; D017475:Receptors, Nerve Growth Factor / Q000096:biosynthesis / Q000235:genetics; D012160:Retina / Q000378:metabolism*; D012165:Retinal Ganglion Cells / Q000378:metabolism / Q000473:pathology; D020133:Reverse Transcriptase Polymerase Chain Reaction / Q000379:methods; D015398:Signal Transduction / Q000502:physiology
chemical_list: D019208:Brain-Derived Neurotrophic Factor; D005136:Eye Proteins; D009414:Nerve Growth Factors; D009419:Nerve Tissue Proteins; D012333:RNA, Messenger; D017978:Receptors, Growth Factor; D017475:Receptors, Nerve Growth Factor; C068313:Ngfr protein, rat; D020813:Receptor, trkB
references.citation: Invest Ophthalmol Vis Sci. 2004 Apr;45(4):1247-58
references.pmid: 15037594
references.citation: Science. 1993 Oct 29;262(5134):695-700
references.pmid: 8235590
references.citation: Neuron. 2003 Jun 19;38(6):899-914
references.pmid: 12818176
references.citation: Proc Natl Acad Sci U S A. 1998 Mar 31;95(7):3978-83
references.pmid: 9520478
references.citation: Curr Biol. 2005 Apr 26;15(8):R302-5
references.pmid: 15854897
references.citation: Biochem Biophys Res Commun. 1995 Aug 15;213(2):715-24
references.pmid: 7646528
references.citation: Invest Ophthalmol Vis Sci. 2000 Aug;41(9):2412-21
references.pmid: 10937548
references.citation: Neurosci Lett. 1987 Jul 9;78(1):29-34
references.pmid: 3614770
references.citation: J Biol Chem. 1999 Sep 10;274(37):26563-71
references.pmid: 10473620
references.citation: Eur J Neurosci. 2005 Oct;22(8):1881-94
references.pmid: 16262628
references.citation: Exp Eye Res. 2005 May;80(5):663-70
references.pmid: 15862173
references.citation: Brain Res. 2004 Oct 1;1022(1-2):195-204
references.pmid: 15353229
references.citation: J Neurosci. 2005 Jun 1;25(22):5455-63
references.pmid: 15930396
references.citation: Nat Neurosci. 2001 Oct;4(10):981-8
references.pmid: 11544482
references.citation: Brain Res. 2005 Sep 28;1057(1-2):17-28
references.pmid: 16139821
references.citation: Exp Eye Res. 1997 Jan;64(1):85-96
references.pmid: 9093024
references.citation: Nature. 2004 Feb 26;427(6977):843-8
references.pmid: 14985763
references.citation: Prog Retin Eye Res. 2005 Mar;24(2):217-40
references.pmid: 15610974
references.citation: Brain Res. 2000 Nov 10;883(1):60-8
references.pmid: 11063988
references.citation: Eur J Neurosci. 2004 Jan;19(2):265-72
references.pmid: 14725620
references.citation: Dev Neurobiol. 2007 Jun;67(7):884-94
references.pmid: 17506493
references.citation: Invest Ophthalmol Vis Sci. 2000 Mar;41(3):764-74
references.pmid: 10711692
references.citation: Mol Endocrinol. 1994 Jan;8(1):59-68
references.pmid: 8152431
references.citation: Prog Neurobiol. 2002 Jun;67(3):203-33
references.pmid: 12169297
references.citation: Vision Res. 1998 May;38(10):1517-24
references.pmid: 9667016
references.citation: Invest Ophthalmol Vis Sci. 1994 Mar;35(3):907-15
references.pmid: 8125754
references.citation: Neuron. 2000 Aug;27(2):265-77
references.pmid: 10985347
references.citation: Nat Neurosci. 2004 Mar;7(3):221-8
references.pmid: 14966521
references.citation: Cell Mol Life Sci. 2001 Jul;58(8):1045-53
references.pmid: 11529497
references.citation: J Biol Chem. 1999 Aug 6;274(32):22569-80
references.pmid: 10428835
references.citation: J Cell Sci. 2000 Sep;113 ( Pt 17):3073-84
references.pmid: 10934045
references.citation: Neuroscience. 2008 Feb 6;151(3):771-9
references.pmid: 18178318
references.citation: J Biol Chem. 1997 Apr 4;272(14):8837-40
references.pmid: 9082996
references.citation: J Neurochem. 1997 Jul;69(1):34-42
references.pmid: 9202291
references.citation: Brain Res. 1995 May 15;679(2):249-54
references.pmid: 7543356
references.citation: Invest Ophthalmol Vis Sci. 2004 Jun;45(6):1854-62
references.pmid: 15161850
references.citation: Invest Ophthalmol Vis Sci. 2003 Oct;44(10):4357-65
references.pmid: 14507880
references.citation: Trends Neurosci. 2005 Jan;28(1):5-11
references.pmid: 15626491
references.citation: J Neurobiol. 2004 Feb 15;58(3):341-54
references.pmid: 14750147
references.citation: J Biol Chem. 2004 Feb 6;279(6):4058-65
references.pmid: 14617628
references.citation: J Neurobiol. 1997 Oct;33(4):395-410
references.pmid: 9322157
references.citation: Prog Retin Eye Res. 1999 Jan;18(1):39-57
references.pmid: 9920498
references.citation: Exp Eye Res. 2007 Aug;85(2):250-8
references.pmid: 17586494
references.citation: Neurochem Res. 2005 Sep;30(9):1163-70
references.pmid: 16292510
references.citation: Neuron. 2004 May 27;42(4):529-33
references.pmid: 15157416
references.citation: Mol Vis. 2001 Aug 15;7:192-201
references.pmid: 11509915
references.citation: Invest Ophthalmol Vis Sci. 2008 Jun;49(6):2478-82
references.pmid: 18515586
references.citation: Proc Natl Acad Sci U S A. 2000 Sep 26;97(20):11020-5
references.pmid: 10995468
references.citation: Mol Vis. 2007 Sep 24;13:1783-92
references.pmid: 17960131
references.citation: J Physiol. 2008 Sep 15;586(18):4393-400
references.pmid: 18565994
references.citation: Jpn J Ophthalmol. 2004 Sep-Oct;48(5):460-4
references.pmid: 15486768
references.citation: Annu Rev Biochem. 2003;72:609-42
references.pmid: 12676795
references.citation: Brain Res Mol Brain Res. 1989 Mar;5(2):93-108
references.pmid: 2469928
references.citation: J Neurosci. 2001 Jan 15;21(2):434-43
references.pmid: 11160424
references.citation: Science. 2001 Nov 30;294(5548):1945-8
references.pmid: 11729324
references.citation: Neuron. 1994 Apr;12(4):747-61
references.pmid: 8068082
references.citation: Science. 1999 Nov 12;286(5443):1358-62
references.pmid: 10558990
references.citation: Proc Natl Acad Sci U S A. 1994 Mar 1;91(5):1632-6
references.pmid: 8127857
references.citation: Science. 1995 Nov 24;270(5240):1326-31
references.pmid: 7481820
references.citation: Neuron. 2001 Dec 6;32(5):767-70
references.pmid: 11738023
references.citation: Invest Ophthalmol Vis Sci. 1997 Nov;38(12):2545-53
references.pmid: 9375574
references.citation: Invest Ophthalmol Vis Sci. 2005 Apr;46(4):1313-21
references.pmid: 15790897
references.citation: Invest Ophthalmol Vis Sci. 1995 Apr;36(5):774-86
references.pmid: 7706025
references.citation: Mol Ther. 2005 Sep;12(3):402-12
references.pmid: 15975850
references.citation: J Biosci. 2001 Jun;26(2):179-91
references.pmid: 11426054
references.citation: Curr Eye Res. 1999 Aug;19(2):188-96
references.pmid: 10420189
references.citation: Invest Ophthalmol Vis Sci. 1988 Sep;29(9):1363-71
references.pmid: 3417421
references.citation: J Neurobiol. 2004 Sep 5;60(3):319-27
references.pmid: 15281070
references.citation: Dev Biol. 1989 Dec;136(2):296-303
references.pmid: 2573550
references.citation: Invest Ophthalmol Vis Sci. 2003 Jan;44(1):164-9
references.pmid: 12506070
references.citation: Dev Neurosci. 2007;29(6):438-51
references.pmid: 17119319
references.citation: J Neurosci. 2004 Nov 17;24(46):10521-9
references.pmid: 15548667
references.citation: Exp Eye Res. 2006 Jul;83(1):51-60
references.pmid: 16530758
references.citation: Brain Res. 2004 Jun 11;1011(1):99-106
references.pmid: 15140649
references.citation: Mol Cell Neurosci. 1999 Jul;14(1):28-40
references.pmid: 10433815
references.citation: Invest Ophthalmol Vis Sci. 1996 Mar;37(4):489-500
references.pmid: 8595949
references.citation: Curr Opin Neurobiol. 2005 Feb;15(1):49-57
references.pmid: 15721744
references.citation: Invest Ophthalmol Vis Sci. 2000 May;41(6):1380-5
references.pmid: 10798653
references.citation: Brain Res. 1994 May 30;647(1):30-6
references.pmid: 8069702
references.citation: J Neurosci. 1993 Jun;13(6):2617-26
references.pmid: 8501527
references.citation: Brain Res. 1993 Feb 5;602(2):304-17
references.pmid: 8448673
references.citation: Vision Res. 2002 Jan;42(2):151-7
references.pmid: 11809469
references.citation: J Biol Chem. 1994 Jun 3;269(22):15819-26
references.pmid: 7515060
references.citation: Science. 1996 Apr 26;272(5261):542-5
references.pmid: 8614802
references.citation: J Neurosci. 1986 Oct;6(10):3031-8
references.pmid: 2876066
references.citation: Curr Opin Neurobiol. 2002 Jun;12(3):268-74
references.pmid: 12049932
references.citation: Curr Opin Neurobiol. 2001 Jun;11(3):297-305
references.pmid: 11399427
references.citation: J Neurosci. 1995 Jul;15(7 Pt 1):4762-85
references.pmid: 7623109
references.citation: Vis Neurosci. 2007 Mar-Apr;24(2):127-39
references.pmid: 17640403
references.citation: Invest Ophthalmol Vis Sci. 2009 May;50(5):2194-200
references.pmid: 19060281
references.citation: Mol Ther. 2005 Mar;11(3):373-81
references.pmid: 15727933
references.citation: Neuron. 2000 Sep;27(3):499-512
references.pmid: 11055433
references.citation: Exp Neurol. 2005 Nov;196(1):184-94
references.pmid: 16126201
references.citation: Invest Ophthalmol Vis Sci. 2000 Feb;41(2):431-42
references.pmid: 10670473
references.citation: Dev Biol. 1997 Apr 1;184(1):1-9
references.pmid: 9142978
references.citation: Invest Ophthalmol Vis Sci. 2007 Jul;48(7):3161-77
references.pmid: 17591886
references.citation: Anal Biochem. 1987 Apr;162(1):156-9
references.pmid: 2440339
references.citation: Invest Ophthalmol Vis Sci. 2000 Oct;41(11):3460-6
references.pmid: 11006239
references.citation: J Biol Chem. 1995 May 26;270(21):12665-9
references.pmid: 7759517